NexgenRx Announces Significant Third Quarter Revenue and EBITDA Growth
Accessnewswireยท2025-11-21 00:55
Financial Performance - NexgenRx reported third-quarter revenue of $4,616,066, reflecting an increase of $546,714 compared to the previous quarter [1] - The company's EBITDA for the third quarter grew to $887,671, an increase of $441,224 [1]